These nanosized fibrils make the bioink semi-translucent which allows cell imaging and analysis. Additionally, this bioink includes fibrinogen that is converted into a fibrin network with thrombin-containing crosslinking solution after printing. This in situ fibrin protein network provides a physiologically relevant wound-healing environment that mimics blood clotting and supports vascularization.
CELLINK FIBRIN contains low levels of endotoxins that allows creation of healthy and diseased tissue models with minimal interference with drugs during drug discovery and development research.
- Available in 3 mL cartridges.
- Includes one bottle of crosslinking agent and one vial of thrombin.
- Sterile production and packaging.
- Seven weeks shelf life.
- For research use only. Not for human use.
|Appearance||White semi-translucent gel|
|Endotoxin level||<5 EU/mL|
|Viscosity||≥7 kPa∙s at 0.01 s-1, ≤3 Pa∙s at 200 s-1, measured at 25°C|